Search Within

Olivia F Wilkins

Formats
  1. Journal Article (3)
  2. Meeting Abstract (2)
Groups
  1. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (5)
  2. Center for Molecular Imaging and Biotechnology (CMIB) (5)
  3. Department of Medicine (5)
  4. GSK Faculty (5)
  5. Solid Tumor Oncology Division (5)
  6. Thoracic Oncology (5)

More Groups

People
  1. Charles Rudin (5)
  2. Mark Kris (5)
  3. Alexander Drilon (4)
  4. Bob Li (4)
  5. Maria Arcila (4)
  6. Michael Offin (4)

More People

Years
  1. 2021 (1)
  2. 2020 (1)
  3. 2019 (1)
  4. 2018 (2)
Publications
  1. Cancer Immunology Research (1)
  2. Clinical Cancer Research (1)
  3. JCO Precision Oncology (1)
  4. Journal of Clinical Oncology (1)
  5. Journal of Thoracic Oncology (1)
Publishers
  1. American Association for Cancer Research (2)
  2. American Society of Clinical Oncology (2)
  3. Elsevier Inc. (1)

Results (5)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • MET exon 14-altered lung cancers and MET inhibitor resistance
    Journal Article

    Guo, R.; Offin, M.; Brannon, A. R.; Chang, J.; Chow, A.; Delasos, L.; Girshman, J.; Wilkins, O.; McCarthy, C. G.; Makhnin, A.; more...
    Clinical Cancer Research (2021)

    Fulltext@MSK | Save
  • CNS metastases in patients with MET exon 14-altered lung cancers and outcomes with crizotinib
    Journal Article

    Offin, M.; Luo, J.; Guo, R.; Lyo, J. K.; Falcon, C.; Dienstag, J.; Wilkins, O.; Chang, J.; Rudin, C. M.; Riely, G.; more...
    JCO Precision Oncology (2020)

    Fulltext@MSK | Save
  • MET inhibitor resistance in patients with MET exon 14-altered lung cancers
    Meeting Abstract

    Guo, R.; Offin, M.; Brannon, A. R.; Chow, A.; Delasos, L.; Somwar, R.; Wilkins, O.; Scott, K.; Tian, Y.; Cecchi, F.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • MET exon 14-altered lung cancers: Central nervous system (CNS) metastases and patterns of CNS progression on MET inhibition
    Meeting Abstract

    Offin, M.; Dienstag, J.; Wilkins, O.; Sabari, J.; Ni, A.; Feldman, D.; Van Voorthuysen, M.; Suzawa, K.; Yu, H.; Riely, G.; more...
    Journal of Thoracic Oncology (2018)

    Fulltext@MSK | Save
  • Safety and efficacy of re-treating with immunotherapy after immune-related adverse events in patients with NSCLC
    Journal Article

    Santini, F. C.; Rizvi, H.; Plodkowski, A. J.; Ni, A.; Lacouture, M. E.; Gambarin-Gelwan, M.; Wilkins, O.; Panora, E.; Halpenny, D. F.; Long, N. M.; more...
    Cancer Immunology Research (2018)

    Fulltext@MSK | Save